James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 100,000 shares at $23.02 ($2.3M) on 2022-10-20, disclosed to the SEC on 2022-10-21.
Open-market sale of $2.3M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.59 | 30,397 | $687K | 30.1% |
| 2 | $22.59 | 30,397 | $687K | 30.1% |
| 3 | $23.37 | 10,861 | $254K | 11.1% |
| 4 | $23.37 | 10,861 | $254K | 11.1% |
| 5 | $23.02 | 8,742 | $201K | 8.8% |
| 6 | $23.02 | 8,742 |
| $201K |
| 8.8% |
| Total | $22.83 avg | 100,000 | $2.3M | 100% |
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |